Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$236.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| 2.8M |
| — |
| — |
| -100.0% |
| Open the original filing on SEC.gov |
| Jul 14 | XOMA | XOMA Royalty Corp | UTENDR | 3.6M | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 26 | KYMR | Kymera Therapeutics, Inc. | SSELL | 51,858 | $106.50 | $5.5M | -39.7% | Open the original filing on SEC.gov |
| Jun 26 | KYMR | Kymera Therapeutics, Inc. | SSELL | 113,289 | $106.50 | $12.1M | -32.1% | Open the original filing on SEC.gov |
| Jun 26 | KYMR | Kymera Therapeutics, Inc. | SSELL | 627,597 | $106.50 | $66.8M | -28.3% | Open the original filing on SEC.gov |
| Jun 26 | KYMR | Kymera Therapeutics, Inc. | SSELL | 837,914 | $106.50 | $89.2M | -29.9% | Open the original filing on SEC.gov |
| Jun 24 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 6,068 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | OLMA | Olema Pharmaceuticals,… | AGRANT◆ | 29,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MLTX | MoonLake Immunotherapeutic… | AGRANT◆ | 22,195 | — | — | — | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV◆ | 772 | — | — | — | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV◆ | 412 | — | — | — | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV◆ | 1,506 | — | — | — | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV◆ | 2,313 | — | — | — | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV | 772,000 | $4.03 | $3.1M | — | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV | 412,000 | $4.03 | $1.7M | — | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV | 1.5M | $4.03 | $6.1M | +118.8% | Open the original filing on SEC.gov |
| May 14 | XOMA | XOMA Royalty Corp | CCONV | 2.3M | $4.03 | $9.3M | +174.9% | Open the original filing on SEC.gov |
| Mar 31 | MLTX | MoonLake Immunotherapeutic… | SSELL | 248,530 | $16.79 | $4.2M | -19.3% | Open the original filing on SEC.gov |
| Mar 31 | MLTX | MoonLake Immunotherapeutic… | SSELL | 1.6M | $16.79 | $26.3M | -19.2% | Open the original filing on SEC.gov |
| Mar 31 | MLTX | MoonLake Immunotherapeutic… | SSELL | 1.9M | $16.79 | $32.4M | -18.9% | Open the original filing on SEC.gov |